Related Experiment Videos
Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular
D Woods1, H Cherwinski, E Venetsanakos
1Cancer Research Institute and Department of Cellular and Molecular Pharmacology, San Francisco, California 94115, USA.
Abstract:
Alterations in the expression of integrin receptors for extracellular matrix (ECM) proteins are strongly associated with the acquisition of invasive and/or metastatic properties by human cancer cells. Despite this, comparatively little is known of the biochemical mechanisms that regulate the expression of integrin genes in cells. Here we demonstrate that the Ras-activated Raf-MEK-extracellular signal-regulated kinase (ERK) signaling pathway can specifically control the expression of individual integrin subunits in a variety of human and mouse cell lines. Pharmacological inhibition of MEK1 in a number of human melanoma and pancreatic carcinoma cell lines led to reduced cell surface expression of alpha6- and beta3-integrin. Consistent with this, conditional activation of the Raf-MEK-ERK pathway in NIH 3T3 cells led to a 5 to 20-fold induction of cell surface alpha6- and beta3-integrin expression. Induced beta3-integrin was expressed on the cell surface as a heterodimer with alphav-integrin; however, the overall level of alphav-integrin expression was not altered by Ras or Raf. Raf-induced beta3-integrin was observed in primary and established mouse fibroblast lines and in mouse and human endothelial cells. Consistent with previous reports of the ability of the Raf-MEK-ERK signaling pathway to induce beta3-integrin gene transcription in human K-562 erythroleukemia cells, Raf activation in NIH 3T3 cells led to elevated beta3-integrin mRNA. However, unlike immediate-early Raf targets such as heparin binding epidermal growth factor and Mdm2, beta3-integrin mRNA was induced by Raf in a manner that was cycloheximide sensitive. Surprisingly, activation of the Raf-MEK-ERK signaling pathway by growth factors and mitogens had little or no effect on beta3-integrin expression, suggesting that the expression of this gene requires sustained activation of this signaling pathway. In addition, despite the robust induction of cell surface alphavbeta3-integrin expression by Raf in NIH 3T3 cells, such cells display decreased spreading and adhesion, with a loss of focal adhesions and actin stress fibers. These data suggest that oncogene-induced alterations in integrin gene expression may participate in the changes in cell adhesion and migration that accompany the process of oncogenic transformation.
Insights
The Ras-activated Raf-MEK-extracellular signal-regulated kinase (ERK) pathway regulates integrin gene expression, impacting cancer cell invasion. This pathway controls specific integrin subunits, affecting cell adhesion and migration during oncogenic transformation.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Integrin receptors mediate cell-extracellular matrix interactions crucial for cancer cell invasion and metastasis.
- Mechanisms regulating integrin gene expression are not fully understood.
- The Ras-Raf-MEK-ERK signaling pathway is implicated in cellular processes including proliferation and survival.
Purpose of the Study:
- To investigate the role of the Ras-activated Raf-MEK-extracellular signal-regulated kinase (ERK) signaling pathway in regulating integrin gene expression.
- To determine how alterations in integrin expression affect cancer cell behavior.
Main Methods:
- Pharmacological inhibition of MEK1 in human cancer cell lines (melanoma, pancreatic carcinoma).
- Conditional activation of the Raf-MEK-ERK pathway in NIH 3T3 cells and other cell types (fibroblasts, endothelial cells).
- Analysis of cell surface integrin expression, mRNA levels, and cell adhesion/spreading assays.
Main Results:
- Inhibition of MEK1 reduced cell surface expression of alpha6- and beta3-integrin in cancer cells.
- Activation of the Raf-MEK-ERK pathway induced alpha6- and beta3-integrin expression in NIH 3T3 cells.
- Raf-induced beta3-integrin expression was mRNA-dependent and required sustained pathway activation, impacting cell adhesion and migration.
Conclusions:
- The Raf-MEK-ERK pathway specifically controls individual integrin subunit expression.
- Altered integrin expression induced by oncogenic signaling pathways may contribute to changes in cell adhesion and migration during cancer progression.
- Targeting this pathway could offer therapeutic strategies for invasive cancers.